Petros Pharmaceuticals, Inc. (PTPI)
PTPI Stock Price Chart
Explore Petros Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PTPI price movements and trends.
PTPI Company Profile
Discover essential business fundamentals and corporate details for Petros Pharmaceuticals, Inc. (PTPI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2 Dec 2020
Employees
18.00
Website
https://www.petrospharma.comCEO
Fady Boctor
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
PTPI Financial Timeline
Browse a chronological timeline of Petros Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$1.58 .
Earnings released on 15 May 2025
EPS came in at -$8.46 .
Stock split effective on 1 May 2025
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2025
EPS came in at -$29.00 falling short of the estimated -$8.25 by -251.52%, while revenue for the quarter reached $725.40K , missing expectations by -43.46%.
Earnings released on 13 Nov 2024
EPS came in at -$13.25 falling short of the estimated -$0.29 by -4.47K%, while revenue for the quarter reached $1.58M , beating expectations by +17.64%.
Earnings released on 14 Aug 2024
EPS came in at -$9.25 falling short of the estimated -$0.77 by -1.10K%, while revenue for the quarter reached $1.42M , beating expectations by +0.03%.
Earnings released on 31 May 2024
EPS came in at $0.13 , while revenue for the quarter reached -$364.25K .
Earnings released on 15 May 2024
EPS came in at -$51.25 falling short of the estimated -$1.44 by -3.46K%, while revenue for the quarter reached $1.39M , meeting expectations.
Earnings released on 15 Nov 2023
EPS came in at -$57.75 , while revenue for the quarter reached $1.67M .
Earnings released on 14 Aug 2023
EPS came in at -$30.00 , while revenue for the quarter reached $1.99M .
Earnings released on 15 May 2023
EPS came in at -$16.50 , while revenue for the quarter reached $2.52M .
Earnings released on 7 Apr 2023
EPS came in at -$7.20 , while revenue for the quarter reached $798.10K .
Stock split effective on 1 Dec 2022
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2022
EPS came in at -$167.50 , while revenue for the quarter reached -$1.46M .
Earnings released on 15 Aug 2022
EPS came in at -$22.50 , while revenue for the quarter reached $4.19M .
Earnings released on 16 May 2022
EPS came in at -$2.50 , while revenue for the quarter reached $2.47M .
Earnings released on 1 Apr 2022
EPS came in at -$180.00 , while revenue for the quarter reached -$867.16K .
Earnings released on 15 Nov 2021
EPS came in at -$42.50 , while revenue for the quarter reached $2.15M .
Earnings released on 17 Aug 2021
EPS came in at -$112.50 , while revenue for the quarter reached $2.46M .
Earnings released on 17 May 2021
EPS came in at -$60.00 falling short of the estimated -$0.29 by -20.59K%, while revenue for the quarter reached $4.08M , beating expectations by +204.15%.
Earnings released on 12 Mar 2021
EPS came in at -$4.92 , while revenue for the quarter reached $2.93M .
Earnings released on 30 Sept 2020
EPS came in at -$9.61 , while revenue for the quarter reached $3.46M .
PTPI Stock Performance
Access detailed PTPI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.